- Home
- IINN vs IPSC Comparison
IINN vs IPSC Comparison
Compare IINN & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- IPSC
- Stock Information
- Founded
- IINN 2018
- IPSC 2019
- Country
- IINN Israel
- IPSC United States
- Employees
- IINN N/A
- IPSC N/A
- Industry
- IINN Medical/Dental Instruments
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- IINN Health Care
- IPSC Health Care
- Exchange
- IINN Nasdaq
- IPSC Nasdaq
- Market Cap
- IINN 40.4M
- IPSC 43.2M
- IPO Year
- IINN 2021
- IPSC 2021
- Fundamental
- Price
- IINN $1.17
- IPSC $0.56
- Analyst Decision
- IINN Strong Buy
- IPSC Strong Buy
- Analyst Count
- IINN 1
- IPSC 5
- Target Price
- IINN $2.00
- IPSC $3.33
- AVG Volume (30 Days)
- IINN 367.7K
- IPSC 486.6K
- Earning Date
- IINN 10-01-2025
- IPSC 11-04-2025
- Dividend Yield
- IINN N/A
- IPSC N/A
- EPS Growth
- IINN N/A
- IPSC N/A
- EPS
- IINN N/A
- IPSC N/A
- Revenue
- IINN $289,000.00
- IPSC $114,128,000.00
- Revenue This Year
- IINN N/A
- IPSC $1,589.94
- Revenue Next Year
- IINN $2,050.00
- IPSC N/A
- P/E Ratio
- IINN N/A
- IPSC N/A
- Revenue Growth
- IINN N/A
- IPSC 5491.77
- 52 Week Low
- IINN $0.40
- IPSC $0.34
- 52 Week High
- IINN $1.65
- IPSC $1.83
- Technical
- Relative Strength Index (RSI)
- IINN 42.39
- IPSC 60.86
- Support Level
- IINN $1.16
- IPSC $0.48
- Resistance Level
- IINN $1.23
- IPSC $0.51
- Average True Range (ATR)
- IINN 0.06
- IPSC 0.03
- MACD
- IINN -0.01
- IPSC 0.01
- Stochastic Oscillator
- IINN 0.00
- IPSC 67.79
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.